Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A prospective cohort study examining the association between the periconceptual vaginal microbiota and first-trimester miscarriage in Kenyan women.

Autor: McClelland RS; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.; Department of Medical Microbiology and Immunology, University of Nairobi, Nairobi, Kenya., Lokken EM; Department of Global Health, University of Washington, Seattle, Washington, USA., Kinuthia J; Department of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya.; Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya., Srinivasan S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Richardson BA; Department of Global Health, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Biostatistics, University of Washington, Seattle, Washington, USA., Jaoko W; Department of Medical Microbiology and Immunology, University of Nairobi, Nairobi, Kenya., Lannon S; Northwest Perinatal, Women's Healthcare Associates, Portland, Oregon, USA., Pulei A; Department of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya.; Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.; Department of Human Anatomy and Medical Physiology, University of Nairobi, Nairobi, Kenya., Fiedler TL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Munch MM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Proll S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., John-Stewart G; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.; Department of Pediatrics, University of Washington, Seattle, Washington, USA., Fredricks DN; Department of Medicine, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Publikováno v: Paediatric and perinatal epidemiology [Paediatr Perinat Epidemiol] 2024 Sep; Vol. 38 (7), pp. 599-611. Date of Electronic Publication: 2024 Jul 01.

Effect of Metronidazole on Concentrations of Vaginal Bacteria Associated with Risk of HIV Acquisition.

Autor: Valint DJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Fiedler TL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Liu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Srinivasan S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Fredricks DN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.

Publikováno v: Research square [Res Sq] 2024 Apr 11. Date of Electronic Publication: 2024 Apr 11.

Optimizing metaproteomics database construction: lessons from a study of the vaginal microbiome.

Autor: Lee EM; Fred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA.; University of Washington , Seattle, Washington, DC, USA., Srinivasan S; Fred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA., Purvine SO; Pacific Northwest National Laboratory , Richland, Washington, DC, USA., Fiedler TL; Fred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA., Leiser OP; Pacific Northwest National Laboratory , Richland, Washington, DC, USA., Proll SC; Fred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA., Minot SS; Fred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA., Deatherage Kaiser BL; Pacific Northwest National Laboratory , Richland, Washington, DC, USA., Fredricks DN; Fred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA.; University of Washington , Seattle, Washington, DC, USA.

Publikováno v: MSystems [mSystems] 2023 Aug 31; Vol. 8 (4), pp. e0067822. Date of Electronic Publication: 2023 Jun 23.

Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity.

Autor: Koyama M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA. Electronic address: mkoyama@fredhutch.org., Hippe DS; Clinical Research Division, FHCC, Seattle, WA 98109, USA., Srinivasan S; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA., Proll SC; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA., Miltiadous O; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Li N; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Zhang P; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Ensbey KS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Hoffman NG; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA., Schmidt CR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Yeh AC; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA., Minnie SA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Strenk SM; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA., Fiedler TL; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA., Hattangady N; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Kowalsky J; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA., Grady WM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA., Degli-Esposti MA; Infection and Immunity Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, WA 6009, Australia., Varelias A; Transplantation Immunology Laboratory, Cancer Research Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, University of Queensland, St Lucia, QLD 4067, Australia., Clouston AD; Molecular and Cellular Pathology, University of Queensland, Brisbane, QLD 4006, Australia., van den Brink MRM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA; Department of Immunology, Sloan Kettering Institute, New York, NY 10065, USA., Dey N; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA., Randolph TW; Clinical Research Division, FHCC, Seattle, WA 98109, USA; Public Health Sciences Division, FHCC, WA 98109, USA., Markey KA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA., Fredricks DN; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA., Hill GR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA. Electronic address: grhill@fredhutch.org.

Publikováno v: Immunity [Immunity] 2023 Aug 08; Vol. 56 (8), pp. 1876-1893.e8. Date of Electronic Publication: 2023 Jul 21.